FORTIS HEALTHCARE
|
FORTIS HEALTHCARE Last 5 Year Financial Ratios History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 13.80 | 10.26 | 7.93 | 7.80 | 7.35 |
| CEPS(Rs) | 20.05 | 15.83 | 13.08 | 12.57 | 14.45 |
| DPS(Rs) | 1.00 | 1.00 | 1.00 | 1.00 | - |
| Book NAV/Share(Rs) | 131.05 | 118.08 | 101.48 | 95.91 | 81.81 |
| Tax Rate(%) | 22.09 | 19.63 | 24.80 | 22.21 | 20.03 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 22.84 | 20.40 | 18.39 | 17.49 | 18.70 |
| EBIT Margin(%) | 18.41 | 15.31 | 14.35 | 14.97 | 19.84 |
| Pre Tax Margin(%) | 14.96 | 12.94 | 12.45 | 12.92 | 17.28 |
| PAT Margin (%) | 11.66 | 10.40 | 9.36 | 10.05 | 13.82 |
| Cash Profit Margin (%) | 16.58 | 15.35 | 14.33 | 15.06 | 19.08 |
| Performance Ratios | |||||
| ROA(%) | 7.29 | 6.14 | 5.15 | 5.36 | 7.08 |
| ROE(%) | 11.32 | 9.77 | 8.66 | 9.44 | 12.85 |
| ROCE(%) | 14.07 | 12.14 | 12.01 | 12.50 | 15.61 |
| Asset Turnover(x) | 0.62 | 0.59 | 0.55 | 0.53 | 0.51 |
| Sales/Fixed Asset(x) | 0.66 | 0.63 | 0.60 | 0.56 | 0.54 |
| Working Capital/Sales(x) | -30.88 | -57.25 | -3.94 | -38.57 | -41.49 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 1.51 | 1.58 | 1.68 | 1.77 | 1.86 |
| Receivable days | 36.55 | 33.12 | 32.02 | 31.70 | 30.96 |
| Inventory Days | 5.01 | 5.22 | 6.10 | 7.12 | 6.37 |
| Payable days | 152.97 | 153.11 | 162.59 | 172.53 | 162.58 |
| Valuation Parameters | |||||
| PER(x) | 57.58 | 68.11 | 52.93 | 33.33 | 39.49 |
| PCE(x) | 39.63 | 44.13 | 32.09 | 20.69 | 20.10 |
| Price/Book(x) | 6.06 | 5.92 | 4.14 | 2.71 | 3.55 |
| Yield(%) | 0.13 | 0.14 | 0.24 | 0.38 | - |
| EV/Net Sales(x) | 6.83 | 6.99 | 4.64 | 3.17 | 3.93 |
| EV/Core EBITDA(x) | 29.18 | 32.89 | 24.47 | 17.17 | 20.50 |
| EV/EBIT(x) | 37.09 | 45.68 | 32.32 | 21.18 | 19.81 |
| EV/CE(x) | 4.88 | 4.90 | 3.75 | 2.51 | 3.15 |
| M Cap / Sales | 6.57 | 6.78 | 4.60 | 3.12 | 3.83 |
| Growth Ratio | |||||
| Net Sales Growth(%) | 17.28 | 12.91 | 9.45 | 10.14 | 41.87 |
| Core EBITDA Growth(%) | 29.05 | 26.73 | 12.28 | 6.09 | 143.08 |
| EBIT Growth(%) | 41.03 | 20.48 | 4.89 | -16.91 | 442.43 |
| PAT Growth(%) | 31.48 | 25.44 | 1.93 | -19.87 | 1,506.38 |
| EPS Growth(%) | 34.56 | 29.28 | 1.72 | 6.06 | 605.74 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | 0.29 | 0.25 | 0.11 | 0.10 | 0.16 |
| Current Ratio(x) | 0.86 | 0.92 | 0.45 | 0.88 | 0.89 |
| Quick Ratio(x) | 0.80 | 0.84 | 0.41 | 0.78 | 0.79 |
| Interest Cover(x) | 5.34 | 6.46 | 7.55 | 7.30 | 7.73 |
| Total Debt/Mcap(x) | 0.05 | 0.04 | 0.03 | 0.04 | 0.04 |
Compare Financial Ratios of peers of FORTIS HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FORTIS HEALTHCARE | ₹71,358.8 Cr | -0.7% | -3.1% | 16.5% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹126,592.0 Cr | -1.2% | 2.7% | 20.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹105,260.0 Cr | -1.9% | 0% | -12.8% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹68,339.1 Cr | -3.8% | 1.9% | 31.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹40,098.7 Cr | -3.2% | 0.1% | 1% | Stock Analytics | |
| GLOBAL HEALTH | ₹36,846.2 Cr | 2.9% | 4.1% | 2.2% | Stock Analytics | |
FORTIS HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FORTIS HEALTHCARE | -0.7% |
-3.1% |
16.5% |
| SENSEX | -2.7% |
-0.2% |
-8% |
You may also like the below Video Courses
